Abstract
Burn trauma is one of the worst injuries suffered worldwide with an incidence of approximately 2 million cases annually [1]. Over the past decades, progress in the treatment of severe burn injuries has significantly decreased morbidity and mortality [2]. The improvements in survival have been most notable in the elderly patient population [3, 4]; however, survival has also improved in severely burned pediatric patients. Four major areas of advancement in burn care have been identified:
-
Fluid resuscitation and early patient management
-
Control of infection
-
Modulation of the hyper-metabolic response
-
Surgery and wound care.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Brigham PA, McLoughlin E (1996) Burn incidence and medical care use in the United States: estimates, trends, and data sources. J Burn Care Rehabil 17(2): 95–107
Pereira C, Murphy K, Herndon D (2004) Outcome measures in burn care. Is mortality dead? Burns 30(8): 761–771
Barrow RE, Herndon DN (1988) Thermal burns, gender, and survival. Lancet 2(8619): 1076–1077
Janzekovic Z (1970) A new concept in the early excision and immediate grafting of burns. J Trauma 10(12): 1103–1108
Merrell SW et al (1989) The declining incidence of fatal sepsis following thermal injury. J Trauma 29(10): 1362–1366
Herndon DN et al (1989) A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg 209(5): 547–553
Barret JP et al (1999) Total burn wound excision of massive pediatric burns in the first 24 hours post burn injury. Ann Burns Fire Disasters XIII(1): 25–27
Barret JP et al (1999) Effect of topical and subcutaneous epinephrine in combination with topical thrombin in blood loss during immediate near-total burn wound excision in pediatric burned patients. Burns 25(6): 509–513
Herndon DN et al (1990) Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 212(4): 424–9; discussion 430-1
Herndon DN et al (1995) Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 221(6): 649–56; discussion 656-659
Dyess D et al (1995) The use of fibrin sealant in burn treatment. In: Schlag G, HJ (eds) Fibrin sealing in surgical and non-surgical fields. Springer, Berlin, pp 120–127
Mittermayr R et al (2006) Skin graft fixation by slow clotting fibrin sealant applied as a thin layer. Burns 32(3): 305–311
Branski LK et al (2007) Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med 35(11): 2615–2623
Carsin H et al (2000) Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. Burns 26(4): 379–387
Herndon DN, Parks DH (1986) Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children. J Trauma 26(2): 149–152
Branski LK et al (2007) Amnion in the treatment of pediatric partial-thickness facial burns. Burns 34(3): 393–399
Barret JP et al (2000) Biobrane versus 1 % silver sulfadiazine in second-degree pediatric burns. Plast Reconstr Surg 105(1): 62–65
Gallagher JJ, Wolf SE, Herndon DN (2007) Burns. In: Townsend CM, Jr (ed) Sabiston Textbook of Surgery. Saunders Elsevier, Philadelphia
Dhennin C (2002) [Methods of covering severe burns]. Soins 2002(669): 45–47
Jones I, Currie L, Martin R (2002) A guide to biological skin substitutes. Br J Plast Surg 55(3): 185–193
Bishop JF (1995) Pediatric considerations in the use of Biobrane in burn wound management. J Burn Care Rehabil 16(3 Pt 1): 331–3; discussion 333-334
Cassidy C et al (2005) Biobrane versus duoderm for the treatment of intermediate thickness burns in children: a prospective, randomized trial. Burns 31(7): 890–893
Demling RH (1995) Use of Biobrane in management of scalds. J Burn Care Rehabil 16(3 Pt 1): 329–330
Lal S et al (2000) Biobrane improves wound healing in burned children without increased risk of infection. Shock 14(3): 314–8; discussion 318-319
Lang EM et al (2005) Biobrane in the treatment of burn and scald injuries in children. Ann Plast Surg 55(5): 485–489
Ou LF et al (1998) Use of Biobrane in pediatric scald burns-experience in 106 children. Burns 24(1): 49–53
Whitaker IS, Prowse S, Potokar TS (2008) A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon. Ann Plast Surg 60(3): 333–337
Uhlig C et al (2007) Suprathel-an innovative, resorbable skin substitute for the treatment of burn victims. Burns 33(2): 221–229
Schwarze H et al (2007) Suprathel, a new skin substitute, in the management of donor sites of split-thickness skin grafts: results of a clinical study. Burns 33(7): 850–854
Schwarze H et al (2008)Suprathel, a new skin substitute, in the management of partial-thickness burn wounds: results of a clinical study. Ann Plast Surg 60(2): 181–185
Maral T et al (1999) Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing. Burns 25(7): 625–635
Robson MC, Krizek TJ (1973) The effect of human amniotic membranes on the bacteria population of infected rat burns. Ann Surg 177(2): 144–149
Robson MC et al (1973) Amniotic membranes as a temporary wound dressing. Surg Gynecol Obstet 136(6): 904–906
Ninman C, Shoemaker P (1975) Human amniotic membranes for burns. Am J Nurs 75(9): 1468–1469
Salisbury RE, Carnes R, McCarthy LR (1980) Comparison of the bacterial clearing effects of different biologic dressings on granulating wounds following thermal injury. Plast Reconstr Surg 66(4): 596–598
Quinby WC, Jr et al (1982) Clinical trials of amniotic membranes in burn wound care. Plast Reconstr Surg 70(6): 711–717
Gajiwala K, Gajiwala AL (2004) Evaluation of lyophilised, gamma-irradiated amnion as a biological dressing. Cell Tissue Bank 5(2): 73–80
Douglas B (1952) Homografts of fetal membranes as a covering for large wounds; especially those from burns; an experimental and clinical study. J Tn State Med Assoc 45(6): 230–235
Haberal M et al (1987) The use of silver nitrate-incorporated amniotic membrane as a temporary dressing. Burns Incl Therm Inj 13(2): 159–163
Ramakrishnan KM, Jayaraman V (1997) Management of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries. Burns 23 [Suppl 1]: S33–36
Ravishanker R, Bath AS, Roy R (2003) ‘Amnion Bank’ the use of long term glycerol preserved amniotic membranes in the management of superficial and superficial partial thickness burns. Burns 29(4): 369–374
Tyszkiewicz JT et al (1999) Amnion allografts prepared in the Central Tissue Bank in Warsaw. Ann Transplant 4(3-4): 85–90
Hennerbichler S et al (2007) The influence of various storage conditions on cell viability in amniotic membrane. Cell Tissue Bank 8: 1–8
Lee EW (1880) Zoografting in a burn case. Boston Med Surg 103(260)
Brennan, Mediskin© I, 2010, Brennan Medical LLC: St Paul, MO
Bromberg BE, Song IC, Mohn MP (1965) The use of pig skin as a temporary biological dressing. Plast Reconstr Surg 36: 80–90
Cohen IKDRFLWJ (1992) Wound healing: biochemical & clinical aspects. W. B. Saunders Co, Philadelphia, xxv, 630 p
Fang Z (1991) Application of skin and skin substitutes to burns wounds. In: Leung P (ed) Burns treatment and research. World Scientific, Singapore, pp 97–106
Forbes P (1969) Advances in the biology of skin hair growth Pergamon, Oxford, pp 419–432
Zawacki BE (1974) Reversal of capillary stasis and prevention of necrosis in burns. Ann Surg 180(1): 98–102
Ersek RA, Denton DR (1984) Silver-impregnated porcine xenografts for treatment of meshed autografts. Ann Plast Surg 13(6): 482–487
Ersek RA, Navarro JA (1990) Maximizing wound healing with silver-impregnated porcine xenograft. Todays OR Nurse 12(12): 4–9
Cope O et al (1947) Expeditious care of full-thickness burn wounds by surgical excision and grafting. Ann Surg 125(1): 1–22
Jackson D et al (1960) Primary excision and grafting of large burns. Ann Surg 152: 167–89
Burke JF et al (1981) Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194(4): 413–428
Heimbach DM et al (2003) Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil 24(1): 42–48
Wainwright DJ (1995) Use of an acellular allograft dermal matrix (AlloDerm) in the management of fullthickness burns. Burns 21(4): 243–248
Sheridan RL, Choucair RJ (1997) Acellular allogenic dermis does not hinder initial engraftment in burn wound resurfacing and reconstruction. J Burn Care Rehabil 18(6): 496–499
Barret JP et al (2000) Cost-efficacy of cultured epidermal autografts in massive pediatric burns. Ann Surg 231(6): 869–876
Sood R et al (2010) Cultured epithelial autografts for coverage of large burn wounds in eighty-eight patients: the Indiana University experience. J Burn Care Res 31(4): 559–568
Wood F., Kolybaba ML, Allen P (2006) The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature. Burns 32(4): 395–401
Wood FM et al (2007) The use of a non-cultured autologous cell suspension and Integra dermal regeneration template to repair full-thickness skin wounds in a porcine model: a one-step process. Burns 33(6): 693–700
Reid MJ et al (2007) Effect of artificial dermal substitute, cultured keratinocytes and split thickness skin graft on wound contraction. Wound Repair Regen 15(6): 889–896
James SE et al (2010) Sprayed cultured autologous keratinocytes used alone or in combination with meshed autografts to accelerate wound closure in difficult-toheal burns patients. Burns 36(3): e10–20
Zweifel CJ et al (2008) Initial experiences using noncultured autologous keratinocyte suspension for burn wound closure. J Plast Reconstr Aesthet Surg 61(11): e1–4
Gerlach JC et al (2011) Method for autologous single skin cell isolation for regenerative cell spray transplantation with non-cultured cells. Int J Artif Organs 34(3): 271–27 9
Hartmann B et al (2007) Sprayed cultured epithelial autografts for deep dermal burns of the face and neck. Ann Plast Surg 58(1): 70–73
Devauchelle B et al (2006) First human face allograft: early report. Lancet 368(9531): 203–209
Pomahac B et al (2011) Face transplantation. Curr Probl Surg 48(5): 293–357
Pomahac B et al (2011) Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant 11(2): 386–393
Soni CV et al (2010) Psychosocial considerations in facial transplantation. Burns 36(7): 959–964
O’Neill H, Godden D (2009) Ethical issues of facial transplantation. Br J Oral Maxillofac Surg 47(6): 443–445
Pushpakumar SB et al (2010) Clinical considerations in face transplantation. Burns 36(7): 951–958
Boyce ST, Glatter R, Kitzmiller WJ (1995) Treatment of chronic wounds with cultured cells and biopolymers: a pilot study. Wounds 1995(7): 24–29
Boyce ST, Supp AP, Swope VB (2002) Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane formation in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Investig Dermatol 118: 565–572
Hansbrough JF et al (1989) Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA 262(15): 2125–2130
Boyce ST, Williams ML (1993) Lipid supplemented medium induces lamellar bodies and precursors of barrier lipids in cultured analogues of human skin. J Invest Dermatol 101(2): 180–184
Prunieras M, Regnier M, Woodley DT (1983) Methods for cultivation of keratinocytes at the air-liquid interface. J Investig Dermatol 81: 28S–33S
Swope VB et al (1997) Regulation of pigmentation in cultured skin substitutes by cytometric sorting of melanocytes and keratinocytes. J Invest Dermatol 109(3): 289–295
Supp DM et al (2000) Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor. J Invest Dermatol 114(1): 5–13
Butler KL et al (2010) Stem cells and burns: review and therapeutic implications. J Burn Care Res 31(6): 874–881
Wu Y et al (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25(10): 2648–2659
Burd A et al (2007) Stem cell strategies in burns care. Burns 33(3): 282–291
Korbling M, Estrov Z, Champlin R (2003) Adult stem cells and tissue repair. Bone Marrow Transplant 32 [Suppl 1]: S23–24
Mansilla E et al (2006) Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc 38(3): 967–969
Weil BR et al (2009) Stem cells in sepsis. Ann Surg 250(1): 19–27
Guenou H et al (2009) Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 374(9703): 1745–1753
Hernandez A, Evers BM (1999) Functional genomics: clinical effect and the evolving role of the surgeon. Arch Surg 134(11): 1209–1215
Khavari PA, Rollman O, Vahlquist A (2002) Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252(1): 1–10
Kozarsky KF, Wilson JM (1993) Gene therapy: adenovirus vectors. Curr Opin Genet Dev 3(3): 499–503
Lu B et al (1997) Topical application of viral vectors for epidermal gene transfer. J Invest Dermatol 108(5): 803–808
Silman NJ, Fooks AR (2000) Biophysical targeting of adenovirus vectors for gene therapy. Curr Opin Mol Ther 2(5): 524–531
Bett AJ, Prevec L, Graham FL (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67(10): 5911–5921
Liechty KW et al (1999) Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 113(3): 375–383
Badillo AT et al (2007) Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res 143(1): 35–42
Deodato B et al (2002) Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 9(12): 777–785
Galeano M et al (2003) Effect of recombinant adenoassociated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit Care Med 31(4): 1017–1025
Chen S et al (2005) Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors. Hum Gene Ther 16(2): 235–247
Carretero M et al (2004) A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J 18(15): 1931–1933
Morgan JR et al (1987) Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237(4821): 1476–1479
Eming SA et al (1995) Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice-implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 105(6): 756–763
Eming SA et al (1998) Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 9(4): 529–539
Eming SA et al (1996) Targeted expression of insulinlike growth factor to human keratinocytes: modification of the autocrine control of keratinocyte proliferation. J Invest Dermatol 107(1): 113–120
Eming SA et al (1999) Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 112(3): 297–302
Hengge UR et al (1995) Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 10(2): 161–166
Vogel JC (2000) Nonviral skin gene therapy. Hum Gene Ther 11(16): 2253–2259
Eriksson E et al (1998) In vivo gene transfer to skin and wound by microseeding. J Surg Res 78(2): 85–91
Nanney LB et al (2000) Boosting epidermal growth factor receptor expression by gene gun transfection stimulates epidermal growth in vivo. Wound Repair Regen 8(2): 117–127
Dileo J et al (2003) Gene transfer to subdermal tissues via a new gene gun design. Hum Gene Ther 14(1): 79–87
Baker LL et al (1997) Effects of electrical stimulation on wound healing in patients with diabetic ulcers. Diabetes Care 20(3): 405–412
Gardner SE, Frantz RA, Schmidt FL (1999) Effect of electrical stimulation on chronic wound healing: a meta-analysis. Wound Repair Regen 7(6): 495–503
Lee PY, Chesnoy S, Huang L (2004) Electroporatic delivery of TGF-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol 123(4): 791–798
Marti G et al (2004) Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model. Gene Ther 11(24): 1780–1785
Felgner PL, Ringold GM (1989) Cationic liposome-mediated transfection. Nature 337(6205): 387–388
Jeschke MG et al (2000) Biodistribution and feasibility of non-viral IGF-I gene transfers in thermally injured skin. Lab Invest 80(2): 151–158
Slama J, Davidson JM, Eriksson E (2001) Gene therapy of wounds. In: Falanga V (ed) Cutaneous wound healing. Taylor & Francis, London, pp 123–140
Alexander MY, Akhurst RJ (1995) Liposome-medicated gene transfer and expression via the skin. Hum Mol Genet 4(12): 2279–2285
Jeschke MG et al (1999) IGF-I gene transfer in thermally injured rats. Gene Ther 6(6): 1015–1020
Sun L et al (1997) Transfection with aFGF cDNA improves wound healing. J Invest Dermatol 108(3): 313–318.
Jeschke MG, Schubert T, Klein D (2004) Exogenous liposomal IGF-I cDNA gene transfer leads to endog enous cellular and physiological responses in an acute wound. Am J Physiol Regul Integr Comp Physiol 286(5): R958–966
Branski LK et al (2010) Pre-clinical evaluation of liposomal gene transfer to improve dermal and epidermal regeneration. Gene Ther 17(6): 770–778
Lynch SE et al (1987) Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA 84(21): 7696–7700
Sprugel KH et al (1987) Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol 129(3): 601–613
Jeschke MG, Klein D (2004) Liposomal gene transfer of multiple genes is more effective than gene transfer of a single gene. Gene Ther 11(10): 847–855
Shea LD et al (1999) DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17(6): 551–554
Fu H et al (2005) A calcium phosphate-based gene delivery system. J Biomed Mater Res A 74(1): 40–48
Eriksson E (2000) Gene transfer in wound healing. Adv Skin Wound Care 13[2 Suppl]: 20–22
Lawrie A et al (2000) Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 7(23): 2023–2027
Chandler LA et al (2000) Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen 8(6): 473–479
Voigt M et al (1999) Cultured epidermal keratinocytes on a microspherical transport system are feasible to reconstitute the epidermis in full-thickness wounds. Tissue Eng 5(6): 563–572
Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89(12): 5547–5551
Breuing K et al (1992) Healing of partial thickness porcine skin wounds in a liquid environment. J Surg Res 52(1): 50–58
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag/Wien
About this chapter
Cite this chapter
Branski, L.K., Dibildox, M., Shahrokhi, S., Jeschke, M.G. (2012). Treatment of burns — established and novel technology. In: Jeschke, M.G., Kamolz, LP., Sjöberg, F., Wolf, S.E. (eds) Handbook of Burns. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0348-7_21
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0348-7_21
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0347-0
Online ISBN: 978-3-7091-0348-7
eBook Packages: MedicineMedicine (R0)